Evidence map›Paper›PMID 28550687›Full record

ArticleOncology research2018

Tanshinone Suppresses Arecoline-Induced Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway.

Lian Zheng, Zhen-Jie Guan, Wen-Ting Pan, Tian-Feng Du, Yu-Jia Zhai, Jia Guo

Open access · hybridAbstract read
In one paragraph

Article in Oncology research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Oral submucous fibrosis: pathogenesis and therapeutic approaches.International journal of oral science · 2025
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Frontiers in pharmacology · 2022
    Review
  13. Potential Application of an Aqueous Extract ofMaterials (Basel, Switzerland) · 2021
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. The Protective Effect of Antioxidants in Areca Nut Extract-Induced Oral Carcinogenesis.Asian Pacific journal of cancer prevention : APJCP · 2020
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lian ZhengOral and Maxillofacial Surgery, The First Affiliated Hospital of Zhengzhou UniversityZhengzhouP.R. China.
Zhen-Jie GuanOral and Maxillofacial Surgery, The First Affiliated Hospital of Zhengzhou UniversityZhengzhouP.R. China.
Wen-Ting PanOral and Maxillofacial Surgery, The First Affiliated Hospital of Zhengzhou UniversityZhengzhouP.R. China.
Tian-Feng DuOral and Maxillofacial Surgery, The First Affiliated Hospital of Zhengzhou UniversityZhengzhouP.R. China.
Yu-Jia ZhaiOral and Maxillofacial Surgery, The First Affiliated Hospital of Zhengzhou UniversityZhengzhouP.R. China.
Jia GuoOral and Maxillofacial Surgery, The First Affiliated Hospital of Zhengzhou UniversityZhengzhouP.R. China.
First Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral submucous fibrosis (OSF) induced by chewing of the areca nut has been considered to be a precancerous lesion with a high probability of developing oral squamous cell carcinoma. Tanshinone (TSN) is the main component extracted from

Indexed as

Epithelial-Mesenchymal TransitionAbietanesAnimalsAnti-Inflammatory Agents, Non-SteroidalApoptosisArecaArecolineCell ProliferationCells, CulturedCholinergic AgonistsDNA MethylationEpigenesis, GeneticGene Expression RegulationHumansMaleMiceAbietanesAnti-Inflammatory Agents, Non-SteroidalArecolineCholinergic AgoniststanshinoneTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID28550687
PMCPMC7844836
OpenAlexW2618856057

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.